South Africa ends J&J probe as it cuts TB drug price
Medical advocacy groups praised Johnson & Johnson for not enforcing its patent on a crucial tuberculosis medication, allowing its production at lower prices following scrutiny by South African authorities.
South Africa ends J&J probe as it cuts TB drug price Read More »